Issue Exp. Reference Date Date Date Date No. -------------------------------------------------------------------------------- [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] -------------------------------------------------------------------------------- [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] -------------------------------------------------------------------------------- [ * ] Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company's application requesting confidential treatment under Rule 24b-2 of the Securities Exchange Act.
Appears in 1 contract
Sources: Access, Option and License Agreement (Immunogen Inc)
Issue Exp. Reference Date Date Date Date No. -------------------------------------------------------------------------------- [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] -------------------------------------------------------------------------------- [ * ] [ * ] [ * ] [ * ] [ * ] [ * ] -------------------------------------------------------------------------------- [ * ] Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company's application requesting confidential treatment under Rule 24b-2 of the Securities Exchange Act.. Attachment B [ * ]
Appears in 1 contract
Sources: Access, Option and License Agreement (Immunogen Inc)